Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Cantor Fitzgerald
Boehringer Ingelheim
US Department of Justice

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,985,321

« Back to Dashboard

Summary for Patent: 5,985,321

Title: Soft gelatin capsule manufacture
Abstract:Soft gelatin capsules having a capsule shell comprising gelatin, plasticizers and, if desired or required, further auxiliary agents, and a capsule filling containing a solvent including a migrateable solvent such as 1,2-propyleneglycol as a solvent in the capsule filling and in the capsule shell. The manufacture of said capsules is improved, if in the process for making the soft gelatin capsules the gelatin bands are cooled with a liquid, and preferably with water.
Inventor(s): Brox; Werner (Beerfelden, DE), Meinzer; Armin (Freiburg, DE), Zande; Horst (Schonbrun, DE)
Assignee: Novartis AG (Summit, NJ) R.P. Scherer GmbH (Eberbach/Baden, DE)
Application Number:08/841,734
Patent Claim Types:
see list of patent claims
Composition; Dosage form;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,985,321

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany43 32 931Sep 28, 1993

International Patent Family for Patent: 5,985,321

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada2302963► Subscribe
Canada2332631► Subscribe
China1108930► Subscribe
China1182842► Subscribe
China1636554► Subscribe
China100473377► Subscribe
Czech Republic9402360► Subscribe
Czech Republic290314► Subscribe
Germany69426408► Subscribe
Germany69435104► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Fish and Richardson
Chinese Patent Office
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: